Invitae Corporation
NVTA
Rank in Stocks
#35783
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Share Price
$0.016
Last synced: 2024-03-11
Market Cap
$3.27M
Change (1 day)
-5.33%
Change (1 year)
5,233.33%
Country
US
Trade Invitae Corporation (NVTA)
Category
Healthcare
Revenue for Invitae Corporation (NVTA)
Revenue in Sep 2023 TTM: $481.58M
According to Invitae Corporation latest financial reports the company's current revenue (TTM) is $481.58M. In 2022 the company made a revenue of $516.30M an increase over the revenue in the year 2021 that was $460.45M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Invitae Corporation from 2016 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $481.58M | -1.11% |
| 2023 | $487.00M | -5.68% |
| 2022 | $516.30M | 12.13% |
| 2021 | $460.45M | 64.68% |
| 2020 | $279.60M | 28.95% |
| 2019 | $216.82M | 46.80% |
| 2018 | $147.70M | 116.50% |
| 2017 | $68.22M | 172.36% |
| 2016 | $25.05M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 9,521.60% |
US
|
|
| $25.11B | 5,113.43% |
US
|
|
| $2.71B | 462.12% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 1,430.78% |
US
|
